XML 41 R31.htm IDEA: XBRL DOCUMENT v3.25.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Aug. 02, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Instruments
The following table provides a summary of the principal value and estimated fair value of the Company’s outstanding debt as of August 2, 2025, February 1, 2025 and August 3, 2024:
August 2,
2025
February 1,
2025
August 3,
2024
(in millions)
Principal Value$985 $987 $989 
Fair Value, Estimated (a)942 940 877 
________________
(a)The estimated fair value of the Company’s publicly traded debt is based on reported transaction prices which are considered Level 2 inputs in accordance with ASC 820, Fair Value Measurement. The estimates presented are not necessarily indicative of the amounts that the Company could realize in a current market exchange.
Fair Value, Liabilities Measured on Recurring Basis
The following table provides a summary of the Company’s contingent consideration recognized at fair value related to the Adore Me acquisition as of August 2, 2025, February 1, 2025, August 3, 2024 and February 3, 2024 (in millions):
Balance Sheet LocationMeasurement LevelAugust 2,
2025
February 1,
2025
August 3,
2024
February 3,
2024
Accrued Expenses and OtherLevel 3$— $— $68 $74 
Other Long-term LiabilitiesLevel 3— — — 18 
The estimated fair value of the contingent consideration is valued using a Scenario-Based method and a Monte Carlo simulation which utilize inputs including discount rates, estimated probability of achievement of certain milestones, forecasted revenues, forecasted EBITDA and volatility rates. These are considered Level 3 inputs in accordance with ASC 820, Fair Value Measurement. Changes in the fair value of the contingent consideration are recorded within General, Administrative and Store Operating Expenses in the Consolidated Statements of Income. For additional information regarding the contingent consideration, see Note 2, “Acquisition.”